After excluding those studies, high resistin levels were still found in cancer patients (SMD = 0.75, 95% CI = 0.63-0.87, I2 = 39.3%, P (for heterogeneity analysis) = 0.087) (Figure S2b). Here, RETN is linked to cancer.